论文信息 - Potential implications of CYP 3 A 4 , CYP 3 A 5 and MDR-1 genetic variants on the efficacy of Lopinavir / Ritonavir ( LPV / r ) monotherapy in HIV-1 patients - 字舞流文

Potential implications of CYP 3 A 4 , CYP 3 A 5 and MDR-1 genetic variants on the efficacy of Lopinavir / Ritonavir ( LPV / r ) monotherapy in HIV-1 patients

H. Jessen | A. Winston | D. Cooper | S. Khoo | S. Emery | A. Clarke | J. Amin | L. Else | P. Chetchotisakd | A. Amara | T. Barber | Anchalee Avinghsanon